PROJECT 1 - INTEGRATION OF HORMONE SIGNALING IN THE PITUITARY GONADOTROPE

项目 1 - 垂体促性腺激素信号传导的整合

基本信息

  • 批准号:
    7683478
  • 负责人:
  • 金额:
    $ 39.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

The precise interplay of hormonal influences that governs gonadotropin hormone production by the pituitary ncludes endocrine, paracrine and autocrine actions of activin and follistatin, hypothalamic gonadotropin- ¿eleasing hormone (GnRH), and gonadal steroid hormones. Our focus will be the cellular and molecular mechanisms of activin, GnRH, and steroid hormone regulation of the pituitary gonadotropins: luteinizing hormone (LH) and follicle-stimulating hormone (FSH), using cultured cells in vitro, and their roles in physiology and pathophysiology, in vivo, using targeted gene deletion in mice. In Aim 1, we will focus on the regulation of the gonadotropin genes by activin, its interactions with GnRH, and the physiological role of activin signaling in the gonadotrope, in vivo, in targeted Smad-deficient mice. In Aim 2, we address the roles of progestins and androgens in both negative and positive regulation of the gonadotropin genes and their nteractions with activin signaling. Further, we will utilize targeted disruption of the progesterone and androgen receptor genes, in vivo, to assess their role within the pituitary and brain, in normal female reproductive function. Both clinical and animal studies underscore the prenatal origin of premature puberty and polycystic ovary syndrome with the common thread being abnormal androgen exposure in utero. We will use models of high-fat feeding and in utero exposure to androgens to invesigate the hypothesis that androgens, acting through the androgen receptor, are causative for advancement of puberty and for development of the hallmarks of polycystic ovary syndrome. Our overall goal is to understand the integration of activin, GnRH, and steroid hormone action in the regulation of LH and FSH in the gonadotrope in normal and pathopysiological states. Thus, the interplay of peptide hormones, growth factors, steroids, receptors, and hypothalamic releasing factors directly and indirectly controlling gonadotropin synthesis will be investigated using the armamentarium of molecular, cellular, genetic, and mouse technologies with the goal of developing a detailed understanding of the molecular mechanisms mediating normal and disordered female reproductive function.
控制垂体促性腺激素产生的激素影响的精确相互作用 包括激活素和卵泡抑素的内分泌、旁分泌和自分泌作用,下丘脑促性腺激素, 促性腺激素释放激素(GnRH)和性腺类固醇激素。我们的重点将是细胞和分子 激活素、GnRH和类固醇激素调节垂体促性腺激素的机制:促黄体生成 激素(LH)和卵泡刺激素(FSH),使用体外培养的细胞,以及它们在 使用小鼠靶向基因缺失进行体内生理学和病理生理学研究。在目标1中,我们将重点关注 激活素对促性腺激素基因的调节,激活素与GnRH的相互作用,以及激活素的生理作用 激活素信号在促性腺细胞,在体内,在靶向Smad缺陷小鼠。在目标2中,我们讨论了 孕激素和雄激素在促性腺激素基因的负性和正性调节中的作用及其 与激活素信号传导的相互作用。此外,我们将利用孕酮的靶向破坏, 雄激素受体基因,在体内,以评估其在垂体和脑内的作用,在正常女性 生殖功能临床和动物研究都强调了青春期提前的产前起源 和多囊卵巢综合征,共同点是子宫内雄激素异常暴露。我们 将使用高脂肪喂养和子宫内暴露于雄激素的模型来研究这一假设, 通过雄激素受体起作用的雄激素是青春期提前和 多囊卵巢综合症的症状有哪些我们的总体目标是了解 激活素、GnRH和类固醇激素在正常人促性腺激素中调节LH和FSH的作用 和病理生理状态。因此,肽类激素、生长因子、类固醇、受体, 下丘脑释放因子直接或间接控制促性腺激素的合成, 使用分子,细胞,遗传和小鼠技术的设备进行研究,目标是 发展一个详细的了解分子机制介导正常和无序 女性生殖功能

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAMELA L MELLON其他文献

PAMELA L MELLON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAMELA L MELLON', 18)}}的其他基金

Neurosecretory Gene Expression in the Hypothalamus
下丘脑的神经分泌基因表达
  • 批准号:
    10619540
  • 财政年份:
    2020
  • 资助金额:
    $ 39.72万
  • 项目类别:
Neurosecretory Gene Expression in the Hypothalamus
下丘脑的神经分泌基因表达
  • 批准号:
    10396658
  • 财政年份:
    2020
  • 资助金额:
    $ 39.72万
  • 项目类别:
Neurosecretory Gene Expression in the Hypothalamus
下丘脑的神经分泌基因表达
  • 批准号:
    10052992
  • 财政年份:
    2020
  • 资助金额:
    $ 39.72万
  • 项目类别:
Neurosecretory Gene Expression in the Hypothalamus
下丘脑的神经分泌基因表达
  • 批准号:
    10239241
  • 财政年份:
    2020
  • 资助金额:
    $ 39.72万
  • 项目类别:
Training in Reproductive Sciences
生殖科学培训
  • 批准号:
    9385648
  • 财政年份:
    2016
  • 资助金额:
    $ 39.72万
  • 项目类别:
Neuroendocrine Actions of Androgens in Female Reproduction
雄激素在女性生殖中的神经内分泌作用
  • 批准号:
    8809606
  • 财政年份:
    2015
  • 资助金额:
    $ 39.72万
  • 项目类别:
Center for Reproductive Science and Medicine
生殖科学与医学中心
  • 批准号:
    8079991
  • 财政年份:
    2010
  • 资助金额:
    $ 39.72万
  • 项目类别:
Horomone Control of Gene Expression in the Gonadotrope
激素对促性腺激素基因表达的控制
  • 批准号:
    7052247
  • 财政年份:
    2005
  • 资助金额:
    $ 39.72万
  • 项目类别:
Endocrine and Growth Factor Regulation in the Pituitary
垂体中的内分泌和生长因子调节
  • 批准号:
    6918355
  • 财政年份:
    2005
  • 资助金额:
    $ 39.72万
  • 项目类别:
Core--Mouse Genetics
核心--小鼠遗传学
  • 批准号:
    6925208
  • 财政年份:
    2005
  • 资助金额:
    $ 39.72万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了